AURORA CANNABIS INC (ACB)
Sector: Medicinal Chemicals & Botanical Products
Industry: Drug Manufacturers - Specialty & Generic
Aurora Cannabis Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 19, 2026 | 4.40 | 4.43 | 4.33 | 4.40 | 116,048 |
| Nov 18, 2026 | 4.52 | 4.58 | 4.38 | 4.40 | 934,119 |
| Nov 17, 2026 | 4.59 | 4.62 | 4.49 | 4.52 | 830,490 |
| Nov 16, 2026 | 4.88 | 4.91 | 4.47 | 4.61 | 2,812,255 |
| Nov 13, 2026 | 4.98 | 5.03 | 4.87 | 4.94 | 1,436,307 |
| Nov 12, 2026 | 5.00 | 5.10 | 4.98 | 4.99 | 1,996,549 |
| Nov 11, 2026 | 5.10 | 5.10 | 5.05 | 5.05 | 699,158 |
| Nov 10, 2026 | 5.14 | 5.29 | 5.09 | 5.11 | 1,431,170 |
| Nov 9, 2026 | 5.25 | 5.30 | 5.15 | 5.16 | 1,910,244 |
| Nov 6, 2026 | 5.10 | 5.24 | 5.08 | 5.24 | 2,087,937 |
| Nov 5, 2026 | 5.20 | 5.30 | 5.05 | 5.19 | 5,130,951 |
| Nov 4, 2026 | 5.16 | 5.26 | 5.10 | 5.24 | 3,182,560 |
| Nov 3, 2026 | 4.71 | 5.20 | 4.71 | 5.16 | 9,011,563 |
| Nov 2, 2026 | 4.16 | 4.34 | 4.09 | 4.22 | 2,040,424 |
| Oct 30, 2026 | 4.03 | 4.09 | 3.98 | 4.06 | 807,143 |
| Oct 29, 2026 | 4.05 | 4.14 | 4.04 | 4.08 | 509,991 |
| Oct 28, 2026 | 4.09 | 4.10 | 3.98 | 4.08 | 555,462 |
| Oct 27, 2026 | 3.90 | 4.16 | 3.90 | 4.15 | 579,159 |
| Oct 26, 2026 | 3.85 | 3.95 | 3.84 | 3.90 | 494,669 |
| Oct 23, 2026 | 3.96 | 3.96 | 3.87 | 3.88 | 602,877 |
| Name | Shares | % | Source |
|---|---|---|---|
Trium Capital LLP · may incl. warrants· filed Nov 2026 | 3.2M | 4.9% | 13G |
K2 PRINCIPAL FUND, L.P. | 1.3M | 2.0% | 13F |
GOLDMAN SACHS GROUP INC | 1.3M | 1.9% | 13F |
Tidal Investments LLC | 1.2M | 1.9% | 13F |
RENAISSANCE TECHNOLOGIES LLC | 878.7K | 1.3% | 13F |
AdvisorShares Investments LLC | 420.1K | 0.6% | 13F |
JANE STREET GROUP, LLC | 300.4K | 0.5% | 13F |
HGC Investment Management Inc. | 207.4K | 0.3% | 13F |
UBS Group AG | 206.1K | 0.3% | 13F |
Point72 Asset Management, L.P. | 203.6K | 0.3% | 13F |
Aurora Cannabis Inc. is a leading company in the global cannabis industry, focusing on the cultivation, production, and sale of various cannabis and cannabis-derived products across Canada and internationally. Beyond its core product offerings, the company engages in a broad spectrum of related activities, including the design and engineering of facilities, cannabis breeding programs, research and development, and both wholesale and retail distribution channels. For medical users, Aurora provides a diverse selection of products such as different strains of dried cannabis, cannabis oils, capsules, and topical kits. Their inventory also includes ancillary items like vaporizers, vaporizer accessories, herb mills (specifically for CanniMed products), grinders, and secure containers for vaporizers.
The company is actively involved in developing advanced medical cannabis products, with ongoing work on oral, topical, edible, and inhalable formulations. Furthermore, Aurora manages CanvasRX, a network of centers dedicated to cannabis counseling and community outreach.
Its service portfolio extends to providing patient support, specialized design and construction services, and comprehensive analytical testing for cannabis products. Aurora Cannabis Inc. manages an extensive collection of brands, including Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC.
The company's main corporate office is located in Edmonton, Canada.
based on 65.75M shares outstanding
30d Avg
1.76M
60d Avg
1.45M
90d Avg
1.31M
Signal8's dilution snapshot of ACB as of Mar 31, 2026 records an effective F-10 shelf registration (effective Feb 14, 2025), an at-the-market sales agreement dated Feb 4, 2026 and an ATM sale closed Aug 18, 2026, from SEC filings. Aurora Cannabis Inc. (NASDAQ: ACB) traded at $4.40 on Nov 19, 2026, unchanged from the previous close of $4.40. 52-week range: $2.56 to $6.36. The company is in the Healthcare sector (Drug Manufacturers - Specialty & Generic).